Home / Technology / New Smart Scale Detects Hypertension Risk
New Smart Scale Detects Hypertension Risk
5 Jan
Summary
- Body Scan 2 measures over 60 biomarkers for health insights.
- It warns users of potential hypertension risk, not diagnosis.
- The device will cost $600 and launch in Q2, pending FDA clearance.

The new Withings Body Scan 2 smart scale, priced at $600, aims to proactively manage user health by monitoring more than 60 biomarkers. This top-tier device alerts users to potential hypertension risks and assesses heart pumping efficiency, distinguishing itself from traditional diagnostic tools.
Expected to launch in the second quarter of 2026, pending U.S. Food and Drug Administration clearance, the Body Scan 2 also screens for glycemic dysregulation. Withings, a pioneer in smart bathroom scales, continues to innovate in the growing market of consumer health technology.
The company reports positive discussions with the FDA regarding the hypertension detection feature, anticipating a streamlined clearance process compared to previous devices. The Body Scan 2 builds on the original Body Scan's capabilities, which included atrial fibrillation detection.




